Evidence map›Paper›PMID 42337822›Full record

ArticleDiabetes, obesity & metabolism2026

The Impact of Missed Doses on Pharmacokinetic Concentrations for Oral Semaglutide in Comparison to Other Glucagon-Like Peptide-1-Based Therapies.

Rune Viig Overgaard, Henrik Agersø, Christian Hollensen, Naveen Rathor, Eric M Bomberg

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rune Viig OvergaardNovo Nordisk A/S, Søborg, Denmark.ORCID https://orcid.org/0000-0001-7095-4270
Henrik AgersøNovo Nordisk A/S, Søborg, Denmark.
Christian HollensenNovo Nordisk A/S, Søborg, Denmark.
Naveen RathorNovo Nordisk A/S, Søborg, Denmark.
Eric M BombergDepartment of Pediatrics, Center for Pediatric Obesity Medicine and Division of Endocrinology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.ORCID https://orcid.org/0000-0002-8037-4314

Funding

Precision Medicine Approaches to Obesity Pharmacotherapy in Youth with Severe ObesityK23DK125668 · NIDDK · UNIVERSITY OF MINNESOTA · PI BOMBERG, ERIC MORRIS · 2020 to 2024
$1.0M
NIDDK NIH HHS K23 DK125668Novo Nordisk A/S
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GLP‐1 analoguepharmacokineticssemaglutidetype 2 diabetesweight management

Identifiers

PMID42337822
PMCPMC13448876

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.